Free services do not produce free access. That gap sits at the center of global health programming and almost nobody budgets for it. A clinic can remove every financial barrier to HIV testing and still watch people walk past the door, because the cost that stops them is not measured in currency. It is measured in what a neighbor might assume, what a spouse might do, or what a village might remember. Marie-Ange Noué, whose work spans the pharmaceutical industry and the Niabang health center in Cameroon, where HIV testing is free in alignment with Ministry of Public Health guidance and patients are supported throughout, argues that most education programs are built backward: content first, trust later. She would reverse the order. “It starts before you write the first piece of content,” she says. “It starts with understanding what people fear, and what seeking help might cost them socially.” The implication for anyone funding or running these programs is uncomfortable. Reach numbers, the metric most organizations report, may be measuring the wrong thing entirely.
The Social Cost Nobody Budgets For
In a community where everyone knows everyone, the walk to a health center is a public act. Noué does not soften this. Someone may worry about being recognized, about what others will assume, and about whether their privacy will hold. Niabang staff conduct educational home visits to bring information and dialogue closer to people, but she is clear that proximity does not resolve the harder problem. Coming in for testing or care, she says, “can still require considerable courage.” Trust has to be built across that entire journey, not delivered at the end of it.
The design consequences are concrete. A program that takes social cost seriously has to account for transport, affordability, and family circumstances, because those determine whether someone can act on what they have learned. It also has to make confidentiality tangible in every interaction rather than stating it as policy. And it has to measure differently. Noué would not stop at counting message recipients. “Are people comfortable asking questions? Do they understand their options? Can they reach appropriate care?” Those three questions are harder to put on a dashboard, which is precisely why they tend to go unasked. Her position on the foundations at Niabang is unsentimental: free testing and ongoing support matter, “but we cannot assume that availability equals access.”
Participation That Can Change The Program
Co-design has become a standard claim in health programming and a mostly empty one. Noué applies a test that exposes the difference. “The test is whether their input can change our decisions,” she says. “If it cannot change the language, the channel, or the priorities, we have not truly shared the design process.” That is a governance standard, not a consultation exercise. It means the people advising a program hold real leverage over its output, and it rules out the common pattern of gathering community input after the framework has already been locked.
Her selection criteria are just as deliberate. She starts from two questions: who lives with the consequences of this disease, and whose perspective we are least likely to hear. People living with the condition, frontline staff, caregivers where appropriate, and trusted community voices all belong at the table, but she would look past the most visible and confident participants to reach the rest. Then comes the constraint that makes this workable in a stigmatized setting. “Participation must be safe,” she says. “Someone should be able to influence a program privately, without publicly disclosing a diagnosis.” This experience is grounded in her work at EMD Serono, where her team supported the HIV therapeutic area and she spearheaded the co-creation of a patient-facing medical resources website with patient representatives. The lesson she took from it cuts against professional instinct: expertise does not tell you what language feels respectful or what makes information usable.
Accuracy And Dignity Are Not In Conflict
Noué draws a firm line between the facts, which must remain faithful to the evidence, and how those facts are explained through language, examples, format, and setting. With HIV, that means communicating the possibilities of effective treatment clearly, including that a person who takes effective treatment and maintains an undetectable viral load does not sexually transmit HIV, alongside the importance of continued treatment and monitoring. Cultural fluency does not dilute the science. It makes the science land. Her framing on misinformation is sharper than most training manuals manage: “Respect does not require us to validate misinformation. It requires us to correct it without humiliating the person who trusted us enough to share it.”
The harder cases are the ones where information was never the obstacle. A person may fully understand their diagnosis and still fear what disclosure would mean for a relationship, a livelihood, or their safety. Noué has seen that tension at Niabang, including situations where fear of stigma makes someone reluctant to disclose their status to a spouse or partner. That creates genuine ethical strain for staff, and she does not pretend otherwise. Patient-centered care, she says, means taking those fears seriously while also taking the health of others seriously, and leaders should acknowledge how difficult that is rather than resolving it with a policy line. Her quality check is similarly practical. She wants the person leaving a conversation to be able to explain, in their own words, what they understood and what options they have. “That tells us much more than whether they nodded while we spoke.” The question she puts to leaders is the one that should open any program review: what makes it difficult for someone to trust us today, and what are we prepared to change?
Follow Marie-Ange Noué on LinkedIn for more insights on community health education, patient participation, and reducing stigma in care delivery.
